NovoCure Ltd financial data

Symbol
NVCR on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
No. 4 The Forum, Grenville Street, St. Helier, Jersey
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 642 % -14.7%
Quick Ratio 23.3 % +15.7%
Debt-to-equity 199 % +18.8%
Return On Equity -50.4 % -57.2%
Return On Assets -16.9 % -40.6%
Operating Margin -40.7 % -42.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 108M shares +1.32%
Common Stock, Shares, Outstanding 108M shares +1.33%
Entity Public Float 1.42B USD -50%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 107M shares +1.51%
Weighted Average Number of Shares Outstanding, Diluted 107M shares +1.51%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 526M USD +0.61%
Cost of Revenue 132M USD +13.4%
Research and Development Expense 215M USD -3.85%
Selling and Marketing Expense 231M USD +23.5%
General and Administrative Expense 162M USD +12.1%
Operating Income (Loss) -214M USD -43.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -172M USD -32.1%
Income Tax Expense (Benefit) 20.4M USD +94%
Net Income (Loss) Attributable to Parent -193M USD -36.7%
Earnings Per Share, Basic -1.81 USD/shares -35.1%
Earnings Per Share, Diluted -1.81 USD/shares -35.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 454M USD +144%
Accounts Receivable, after Allowance for Credit Loss, Current 65.1M USD -13%
Inventory, Net 42.4M USD +33.6%
Assets, Current 1B USD -7.92%
Property, Plant and Equipment, Net 58.9M USD +61.6%
Operating Lease, Right-of-Use Asset 33M USD +29.2%
Other Assets, Noncurrent 14.9M USD +33.7%
Assets 1.12B USD -4.51%
Employee-related Liabilities, Current 51M USD +25.2%
Contract with Customer, Liability, Current 15.9M USD
Liabilities, Current 160M USD +7.7%
Long-term Debt and Lease Obligation 0 USD -100%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 25.6M USD +28.2%
Other Liabilities, Noncurrent 18K USD -86.8%
Liabilities 762M USD +2.68%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.15M USD -54.1%
Retained Earnings (Accumulated Deficit) -1.02B USD -23.2%
Stockholders' Equity Attributable to Parent 359M USD -16.8%
Liabilities and Equity 1.12B USD -4.51%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -88.2M USD -597%
Net Cash Provided by (Used in) Financing Activities 10.8M USD -38.5%
Net Cash Provided by (Used in) Investing Activities 348M USD +199%
Common Stock, Shares, Issued 108M shares +1.33%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 271M USD +203%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 457M USD +145%
Interest Paid, Excluding Capitalized Interest, Operating Activities 6K USD -85.4%
Deferred Tax Assets, Valuation Allowance 375M USD +3.88%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.09 pure 0%
Deferred Tax Assets, Gross 386M USD +4.19%
Operating Lease, Liability 35.6M USD +45.1%
Depreciation 3.94M USD +26.9%
Payments to Acquire Property, Plant, and Equipment 32.8M USD +46.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -194M USD -36.5%
Lessee, Operating Lease, Liability, to be Paid 42.3M USD +49%
Property, Plant and Equipment, Gross 79.4M USD +41.2%
Operating Lease, Liability, Current 8.22M USD +41.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.13M USD +54.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.75M USD +40.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.7M USD +74.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.56M USD +46.3%
Deferred Tax Assets, Operating Loss Carryforwards 99.7M USD +52.3%
Current Income Tax Expense (Benefit) 15.3M USD +43.2%
Unrecognized Tax Benefits 18K USD -76.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.32M USD +30.1%
Additional Paid in Capital 1.39B USD +9.59%
Deferred Tax Assets, Net of Valuation Allowance 10.7M USD +16.6%
Share-based Payment Arrangement, Expense 111M USD -8.58%
Interest Expense 4.91M USD -39.5%